2019 Moffitt Update: Brain and Spinal Tumors Conference
- Program Information
- Accreditation Info.
- ABTA Patient Program
- Industry and Exhibits
REGISTER TO ATTEND TODAY!
FRIDAY, March 15, 2019
(Pre-Conference Dinner: Thursday, March 14, 2019)
Hilton Tampa Downtown • 211 North Tampa Street • Bayshore Ballroom
Recent discovery efforts in glioblastoma have focused on understanding the molecular genetics of GBM, the sensitivity of GBM to immunotherapy-based approaches, the mechanisms of response and resistance to molecularly targeted agents, and novel approaches for delivering therapy. While these efforts have generated optimism among neuro-oncologists, not all clinicians are incorporating these advances into clinical practice for the diagnosis and treatment of GBM.
Spinal tumors also represent a clinical challenge in the treatment of CNS tumors. Spinal oncology is managed by a diverse array of providers, leading to confusion regarding best practices for disease management that can result in sub-optimal outcomes for patients.
Understanding the recent advances in the diagnosis and treatment of GBM and spinal tumors have provided promise for improving patient outcomes. However, given the rapid pace of developments, clinicians may not be aware of these advances. Through an interdisciplinary discussion led by Moffitt Cancer Center brain and spinal tumor experts, topics ranging the spectrum from localized to disseminated disease will provide the most up-to-date information, approach, and practical management considerations, which in turn will help to optimize patient outcomes. Our expert faculty will facilitate an engaging and interactive experience for participants.
|Thursday, March 14, 2019|
|5:00 pm||6:00 pm||Exhibitors||Reception|
|6:00 pm||7:00 pm||Edward Benzel, MD||A Biomechanical and Geometric Approach to the Surgery of Spine Tumors|
|7:00 pm||9:00 pm||Dinner|
|Friday, March 15, 2019|
|7:00 am||7:50 am||Exhibitors||Breakfast|
|7:50 am||8:10 am||James Liu, MD||Welcome and introduction|
|Session 1||Spinal Tumors|
|8:00 am||8:25 am||Nam Tran, MD, PhD||The role of DTI in spinal cord tumor surgery|
|8:30 am||8:55 am||Michael Yu, MD||Advances in radiation treatment for spinal tumors|
|9:00 am||9:25 am||Rigoberto Nunez, MD||Role of physical medicine and rehabilitation for spinal tumor patients|
|9:30 am||9:55 am||Edward Benzel, MD||Spine tumor management in the 21st Century|
|Session 2||Metastatic Brain Tumors|
|10:00 am||10:25 am||Edwin Peguero, MD||Update on anti-epileptic drugs for metastatic brain tumors|
|10:30 am||10:55 am||Nikhil Khushalani, MD||Melanoma brain metastasis: a clinical view|
|11:00 am||11:25 am||Michael Vogelbaum, MD, PhD||Focal vs global treatment of metastatic brain tumors|
|11:30 am||11:55 am||Peter Forsyth, MD||They glitter but are they gold? CSF-CTCs in melanoma leptomeningeal disease|
|12:00 pm||1:15 pm||Exhibitors|
|1:20 pm||1:40 pm||Christine Walko, PharmD||Translation of somatic genomic analysis into the neuro-oncology clinic|
|1:40 pm||2:20 pm||David Reardon, MD||Immunotherapy for gliomas|
|2:20 pm||2:50 pm||Edjah Nduom, MD||Cytokine microdialysis for immune monitoring of GBM patients|
|2:50 pm||3:15 pm||Solmaz Sahebjam, MD||GBM Clinical trials update|
|Session 4||New Frontiers|
|3:15 pm||3:40 pm||Robert Macaulay, MD||Molecular neuropathology in action: updates on the WHO classification of CNS tumors|
|3:40 pm||4:05 pm||Michael Vogelbaum, MD, PhD||Drug delivery to gliomas|
|4:05 pm||4:30 pm||Arnold Etame, MD, PhD||Advances and innovations in surgical resection of gliomas: the Moffitt way|
|4:30 pm||4:55 pm||Tim Robinson, MD, PhD||Advancing treatment paradigms in radiation for brain tumors|
In support of improving patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.
Rush University Medical Center designates this Live Activity for a maximum of eight (8) AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Rush University designates this live activity for eight (8) Continuing Education credits. This activity will fulfill Category 2 contact hour requirements for pharmacology for ANCC certified advanced practice nurses.
This program is approved for 8.0 hours (0.8 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
The address of the hotel we have negotiated special pricing for is
Hilton Tampa Downtown
211 North Tampa Street
Tampa, FL 33602
If you call to make your reservation, please provide the hotel with the following information:
Group Name: 2019 Moffitt Update: Brain and Spinal Tumors
Group Code: MFBST
Check-in: March 14, 2019
Check-out: March 15 2019.
ABTA Patient Program
The ABTA Patient Program registration link is coming soon... please check back!
Industry and Exhibits
ADDITIONAL INFORMATION COMING SOON...
Register for the Conference